Global Cardioembolic Stroke Closure Devices 麻豆原创 Research Report 2025

Publication ID:

PB502256041

Publication Date:

February 13, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Cardioembolic Stroke Closure Devices was valued at US$ 1528 million in the year 2024 and is projected to reach a revised size of US$ 3510 million by 2031, growing at a CAGR of 12.8% during the forecast period.
Cardioembolic stroke occluder products mainly consist of PFO occluder and LAA occluder.
The cardioembolic stroke occluder market is driven by the increasing incidence of ischemic strokes caused by cardioembolism and the growing demand for minimally invasive treatment options. Cardioembolic stroke occluders are medical devices used to prevent recurrent strokes by closing off the source of the emboli in the heart. The rise in cardiovascular diseases and atrial fibrillation contribute to market growth as these conditions increase the risk of cardioembolic strokes. Moreover, advancements in medical technology and the development of innovative occluder designs have improved the safety and efficacy of the procedure. However, the market also faces challenges, including the complexity of treating cardioembolic strokes and the need for specialized training for healthcare professionals. Additionally, addressing the cost of occluder devices and ensuring appropriate patient selection can pose obstacles for widespread adoption. To succeed, companies must focus on research and development to offer advanced and reliable cardioembolic stroke occluders, collaborate with healthcare providers to promote awareness and training, and address the challenges to meet the increasing demand for effective and minimally invasive treatment options for cardioembolic strokes.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cardioembolic Stroke Closure Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardioembolic Stroke Closure Devices.
The Cardioembolic Stroke Closure Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cardioembolic Stroke Closure Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardioembolic Stroke Closure Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore & Associates
Starway
Coherex Medical
Cardia
MicroPort
Segment by Type
PFO Closure Devices
LAA Closure Devices
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cardioembolic Stroke Closure Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cardioembolic Stroke Closure Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Cardioembolic Stroke Closure Devices 麻豆原创 Overview
1.1 Product Definition
1.2 Cardioembolic Stroke Closure Devices by Type
1.2.1 Global Cardioembolic Stroke Closure Devices 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 PFO Closure Devices
1.2.3 LAA Closure Devices
1.3 Cardioembolic Stroke Closure Devices by Application
1.3.1 Global Cardioembolic Stroke Closure Devices 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Cardioembolic Stroke Closure Devices 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Cardioembolic Stroke Closure Devices Revenue 2020-2031
1.4.2 Global Cardioembolic Stroke Closure Devices Sales 2020-2031
1.4.3 Global Cardioembolic Stroke Closure Devices 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cardioembolic Stroke Closure Devices 麻豆原创 Competition by Manufacturers
2.1 Global Cardioembolic Stroke Closure Devices Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Cardioembolic Stroke Closure Devices Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Cardioembolic Stroke Closure Devices Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cardioembolic Stroke Closure Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cardioembolic Stroke Closure Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cardioembolic Stroke Closure Devices, Product Type & Application
2.7 Global Key Manufacturers of Cardioembolic Stroke Closure Devices, Date of Enter into This Industry
2.8 Global Cardioembolic Stroke Closure Devices 麻豆原创 Competitive Situation and Trends
2.8.1 Global Cardioembolic Stroke Closure Devices 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Cardioembolic Stroke Closure Devices Players 麻豆原创 Share by Revenue
2.8.3 Global Cardioembolic Stroke Closure Devices 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cardioembolic Stroke Closure Devices 麻豆原创 Scenario by Region
3.1 Global Cardioembolic Stroke Closure Devices 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cardioembolic Stroke Closure Devices Sales by Region: 2020-2031
3.2.1 Global Cardioembolic Stroke Closure Devices Sales by Region: 2020-2025
3.2.2 Global Cardioembolic Stroke Closure Devices Sales by Region: 2026-2031
3.3 Global Cardioembolic Stroke Closure Devices Revenue by Region: 2020-2031
3.3.1 Global Cardioembolic Stroke Closure Devices Revenue by Region: 2020-2025
3.3.2 Global Cardioembolic Stroke Closure Devices Revenue by Region: 2026-2031
3.4 North America Cardioembolic Stroke Closure Devices 麻豆原创 Facts & Figures by Country
3.4.1 North America Cardioembolic Stroke Closure Devices 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cardioembolic Stroke Closure Devices Sales by Country (2020-2031)
3.4.3 North America Cardioembolic Stroke Closure Devices Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cardioembolic Stroke Closure Devices 麻豆原创 Facts & Figures by Country
3.5.1 Europe Cardioembolic Stroke Closure Devices 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cardioembolic Stroke Closure Devices Sales by Country (2020-2031)
3.5.3 Europe Cardioembolic Stroke Closure Devices Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cardioembolic Stroke Closure Devices 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Cardioembolic Stroke Closure Devices 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cardioembolic Stroke Closure Devices Sales by Region (2020-2031)
3.6.3 Asia Pacific Cardioembolic Stroke Closure Devices Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Cardioembolic Stroke Closure Devices 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Cardioembolic Stroke Closure Devices 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cardioembolic Stroke Closure Devices Sales by Country (2020-2031)
3.7.3 Latin America Cardioembolic Stroke Closure Devices Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cardioembolic Stroke Closure Devices 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Cardioembolic Stroke Closure Devices 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cardioembolic Stroke Closure Devices Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cardioembolic Stroke Closure Devices Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cardioembolic Stroke Closure Devices Sales by Type (2020-2031)
4.1.1 Global Cardioembolic Stroke Closure Devices Sales by Type (2020-2025)
4.1.2 Global Cardioembolic Stroke Closure Devices Sales by Type (2026-2031)
4.1.3 Global Cardioembolic Stroke Closure Devices Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Cardioembolic Stroke Closure Devices Revenue by Type (2020-2031)
4.2.1 Global Cardioembolic Stroke Closure Devices Revenue by Type (2020-2025)
4.2.2 Global Cardioembolic Stroke Closure Devices Revenue by Type (2026-2031)
4.2.3 Global Cardioembolic Stroke Closure Devices Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Cardioembolic Stroke Closure Devices Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cardioembolic Stroke Closure Devices Sales by Application (2020-2031)
5.1.1 Global Cardioembolic Stroke Closure Devices Sales by Application (2020-2025)
5.1.2 Global Cardioembolic Stroke Closure Devices Sales by Application (2026-2031)
5.1.3 Global Cardioembolic Stroke Closure Devices Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Cardioembolic Stroke Closure Devices Revenue by Application (2020-2031)
5.2.1 Global Cardioembolic Stroke Closure Devices Revenue by Application (2020-2025)
5.2.2 Global Cardioembolic Stroke Closure Devices Revenue by Application (2026-2031)
5.2.3 Global Cardioembolic Stroke Closure Devices Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Cardioembolic Stroke Closure Devices Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Cardioembolic Stroke Closure Devices Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Cardioembolic Stroke Closure Devices Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Company Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Cardioembolic Stroke Closure Devices Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boston Scientific Cardioembolic Stroke Closure Devices Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 LifeTech
6.3.1 LifeTech Company Information
6.3.2 LifeTech Description and Business Overview
6.3.3 LifeTech Cardioembolic Stroke Closure Devices Sales, Revenue and Gross Margin (2020-2025)
6.3.4 LifeTech Cardioembolic Stroke Closure Devices Product Portfolio
6.3.5 LifeTech Recent Developments/Updates
6.4 Lepu Medical
6.4.1 Lepu Medical Company Information
6.4.2 Lepu Medical Description and Business Overview
6.4.3 Lepu Medical Cardioembolic Stroke Closure Devices Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lepu Medical Cardioembolic Stroke Closure Devices Product Portfolio
6.4.5 Lepu Medical Recent Developments/Updates
6.5 Occlutech
6.5.1 Occlutech Company Information
6.5.2 Occlutech Description and Business Overview
6.5.3 Occlutech Cardioembolic Stroke Closure Devices Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Occlutech Cardioembolic Stroke Closure Devices Product Portfolio
6.5.5 Occlutech Recent Developments/Updates
6.6 W. L. Gore & Associates
6.6.1 W. L. Gore & Associates Company Information
6.6.2 W. L. Gore & Associates Description and Business Overview
6.6.3 W. L. Gore & Associates Cardioembolic Stroke Closure Devices Sales, Revenue and Gross Margin (2020-2025)
6.6.4 W. L. Gore & Associates Cardioembolic Stroke Closure Devices Product Portfolio
6.6.5 W. L. Gore & Associates Recent Developments/Updates
6.7 Starway
6.7.1 Starway Company Information
6.7.2 Starway Description and Business Overview
6.7.3 Starway Cardioembolic Stroke Closure Devices Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Starway Cardioembolic Stroke Closure Devices Product Portfolio
6.7.5 Starway Recent Developments/Updates
6.8 Coherex Medical
6.8.1 Coherex Medical Company Information
6.8.2 Coherex Medical Description and Business Overview
6.8.3 Coherex Medical Cardioembolic Stroke Closure Devices Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Coherex Medical Cardioembolic Stroke Closure Devices Product Portfolio
6.8.5 Coherex Medical Recent Developments/Updates
6.9 Cardia
6.9.1 Cardia Company Information
6.9.2 Cardia Description and Business Overview
6.9.3 Cardia Cardioembolic Stroke Closure Devices Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cardia Cardioembolic Stroke Closure Devices Product Portfolio
6.9.5 Cardia Recent Developments/Updates
6.10 MicroPort
6.10.1 MicroPort Company Information
6.10.2 MicroPort Description and Business Overview
6.10.3 MicroPort Cardioembolic Stroke Closure Devices Sales, Revenue and Gross Margin (2020-2025)
6.10.4 MicroPort Cardioembolic Stroke Closure Devices Product Portfolio
6.10.5 MicroPort Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cardioembolic Stroke Closure Devices Industry Chain Analysis
7.2 Cardioembolic Stroke Closure Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cardioembolic Stroke Closure Devices Production Mode & Process Analysis
7.4 Cardioembolic Stroke Closure Devices Sales and 麻豆原创ing
7.4.1 Cardioembolic Stroke Closure Devices Sales Channels
7.4.2 Cardioembolic Stroke Closure Devices Distributors
7.5 Cardioembolic Stroke Closure Devices Customer Analysis
8 Cardioembolic Stroke Closure Devices 麻豆原创 Dynamics
8.1 Cardioembolic Stroke Closure Devices Industry Trends
8.2 Cardioembolic Stroke Closure Devices 麻豆原创 Drivers
8.3 Cardioembolic Stroke Closure Devices 麻豆原创 Challenges
8.4 Cardioembolic Stroke Closure Devices 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore & Associates
Starway
Coherex Medical
Cardia
MicroPort

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.